Telix Historical Cash Flow
| TLX Stock | 25.74 0.80 3.21% |
Analysis of Telix Pharmaceuticals cash flow over time is an excellent tool to project Telix Pharmaceuticals future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as Capital Expenditures of 11.3 M or Total Cash From Operating Activities of 25.1 M as it is a great indicator of Telix Pharmaceuticals ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Telix Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Telix Pharmaceuticals is a good buy for the upcoming year.
Telix |
About Telix Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Telix balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Telix's non-liquid assets can be easily converted into cash.
Telix Pharmaceuticals Cash Flow Chart
Add Fundamental
Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Total Cashflows From Investing Activities
The net amount of cash used in or generated from a company's investment activities, such as purchasing or selling assets, during a reporting period.Capital Expenditures
Capital Expenditures are funds used by Telix Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Telix Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Telix Pharmaceuticals' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Telix Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Telix Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, Telix Pharmaceuticals' Stock Based Compensation is comparatively stable compared to the past year. Free Cash Flow is likely to gain to about 13.7 M in 2024, despite the fact that Total Cashflows From Investing Activities is likely to grow to (14.5 M).
Telix Pharmaceuticals cash flow statement Correlations
Click cells to compare fundamentals
Telix Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Telix Pharmaceuticals cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Sale Purchase Of Stock | 45.3M | (130K) | 3.8M | (7.8M) | (7.0M) | (6.7M) | |
| Change In Cash | 18.8M | 33.3M | (55.9M) | 94.3M | 6.9M | 6.6M | |
| Net Borrowings | (1.2M) | (904K) | (936K) | 1.7M | 2.0M | 2.1M | |
| Total Cashflows From Investing Activities | (468K) | (1.1M) | (2.7M) | (17.0M) | (15.3M) | (14.5M) | |
| Other Cashflows From Financing Activities | (1.6M) | (502K) | (596K) | (1.3M) | (2.2M) | (2.3M) | |
| Depreciation | 4.2M | 4.9M | 5.2M | 5.4M | 6.9M | 7.3M | |
| Other Non Cash Items | 9.7M | 18.7M | 31.5M | 41.0M | 60.5M | 63.5M | |
| Capital Expenditures | 468K | 322K | 1.3M | 13.9M | 10.8M | 11.3M | |
| Total Cash From Operating Activities | (23.3M) | 2.0M | (59.3M) | (64.0M) | 23.9M | 25.1M | |
| Change To Account Receivables | (3.6M) | (328K) | (7.2M) | (19.9M) | (27.4M) | (26.0M) | |
| Change To Operating Activities | 198K | (193K) | 2.6M | (3.7M) | (3.3M) | (3.2M) | |
| Net Income | (27.9M) | (44.9M) | (80.5M) | (104.1M) | 5.2M | 5.5M | |
| Total Cash From Financing Activities | 42.7M | 34.1M | 2.8M | 175.0M | 10.2M | 9.7M | |
| Change To Netincome | 659K | 10.2M | 18.6M | 35.7M | 41.1M | 43.2M | |
| Change To Liabilities | 3.0M | 32.4M | 4.8M | 27.6M | 31.8M | 33.4M | |
| Investments | (468K) | (1.1M) | (2.7M) | (17.0M) | (25.5M) | (24.2M) | |
| Stock Based Compensation | 1.3M | 2.3M | 1.3M | 8.1M | 8.8M | 9.2M | |
| Free Cash Flow | (23.8M) | 1.6M | (60.7M) | (77.8M) | 13.1M | 13.7M | |
| Change In Working Capital | (361K) | 31.8M | (2.6M) | (1.0M) | (57.5M) | (54.7M) | |
| Begin Period Cash Flow | 25.8M | 44.6M | 77.9M | 22.0M | 116.3M | 122.1M | |
| End Period Cash Flow | 44.6M | 77.9M | 22.0M | 116.3M | 123.2M | 72.1M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Telix Stock Analysis
When running Telix Pharmaceuticals' price analysis, check to measure Telix Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Telix Pharmaceuticals is operating at the current time. Most of Telix Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Telix Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Telix Pharmaceuticals' price. Additionally, you may evaluate how the addition of Telix Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.